The Claim
In adult female mice undergoing progressive weighted wheel running, frequent rapamycin administration at a dose of 2 mg/kg three times per week prevents the reduction in adiposity typically induced by exercise when compared to vehicle or intermittent dosing, indicating that consistent mTOR inhibition may interfere with fat loss during high-volume physical activity.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In female mice that run a lot, taking rapamycin frequently stops them from losing fat — even though exercise usually helps them slim down.
See the scientific wording
In adult female mice undergoing progressive weighted wheel running, frequent rapamycin dosing (2mg/kg three times weekly) prevents the exercise-induced reduction in adiposity seen with vehicle or intermittent dosing, suggesting that frequent mTOR inhibition may interfere with fat loss during high-volume exercise.
What the research says
1 studyThe study found that giving rapamycin frequently to exercising mice caused worse metabolic health, which supports the idea that it might block fat loss even if the mice were still getting stronger.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.